Skip to main content
. 2021 Feb 1;39(6):667–680. doi: 10.1007/s40273-021-01000-1

Table 1.

Pre- and post-weighting results using entropy balancing

Weighting covariates Details Individuals with depression (n = 223) Unmatched control group (n = 4540) Matched control group (n = 223a)
Sociodemographic and socioeconomic covariates
 Age (mean) Mean 51.7 49.5 51.6
 Sex (% female) Male = 0, female = 1 68.2 48.9 68.0
 Education level (%) CASMIN classification
  Low 32.7 28.5 32.8
  Middle 50.7 50.9 50.6
  High 16.6 20.6 16.6
 Income (€) Mean (equivalent income) 1408.6 1558.6 1406.2
 Marital status (%)
  Married, living with partner 52.5 65.0 52.5
  Married, separated from partner 2.2 1.4 2.2
  Single 24.2 23.8 24.2
  Divorced 12.1 5.5 12.1
  Widowed 9.0 4.3 9.0
 Community size (%)
  Rural Inhabitants: < 5000 13.9 18.4 14.0
  Small town Inhabitants: 5000 to < 20,000 20.6 25.6 20.6
  Mid-sized town Inhabitants: 20,000 to < 100,000 27.4 29.1 27.3
  Large town Inhabitants: ≥ 100,000 38.1 26.9 38.1
 Region (%) Nielsen areas
  North-West 13.9 12.6 13.9
  North Rhine-Westphalia 18.8 18.5 18.8
  Central 16.1 12.1 16.1
  East (North) 16.1 17.4 16.1
  East (South) 10.8 14.4 10.8
  Bavaria 13.0 12.9 13.0
  Baden-Wuerttemberg 11.2 12.0 11.2
 Physician density (%) Physicians per 100,000 inhabitants
  Approximately 124 12.6 19.0 12.7
  Approximately 144 35.9 38.7 35.8
  Approximately 149 13.5 15.9 13.5
  Approximately 233 38.1 26.5 38.1
Clinical covariates
 Health status and risk factors
  Recognized disability (%) No = 0, yes = 1 29.2 12.1 29.1
  Body-mass-index (mean) kg/m2 28.0 26.7 27.9
  Contraceptive pill use (%) No = 0, yes = 1 56.5 38.5 56.4
  Hearing aid (%) No = 0, yes = 1 4.9 3.3 4.9
  Physical activity (%) 4 categories (sporting hours per week in the preceding 3 months) 63.2 69.8 63.2
  Smoker status (%) No = 0, yes = 1 (including occasional smokers) 32.3 25.5 32.3
  Vision aid (%) No = 0, yes = 1 82.5 74.6 82.4
 Comorbidities
  Arthrosis/degenerative joint disease (%) No = 0, yes = 1 (lifetime prevalence) 34.1 20.1 34.0
  Bronchial asthma (%) No = 0, yes = 1 (lifetime prevalence) 9.9 7.4 9.9
  Cancer (%) No = 0, yes = 1 (lifetime prevalence) 10.3 6.3 10.3
  Chronic inflammatory bowel disease (%) No = 0, yes = 1 (12-month prevalence) 3.1 0.3 3.1
  Diabetes (%) No = 0, yes = 1 (lifetime prevalence) 13.0 6.8 13.0
  Epilepsy (%) No = 0, yes = 1 (lifetime prevalence) 3.1 1.0 3.1
  Gastroduodenal ulcer (%) No = 0, yes = 1 (12-month prevalence) 1.8 0.4 1.8
  Hepatic cirrhosis (%) No = 0, yes = 1 (lifetime prevalence) 0.9 0.2 0.9
  Hepatitis (%) No = 0, yes = 1 (lifetime prevalence) 6.7 5.8 6.7
  Hypertension (%) No = 0, yes = 1 (lifetime prevalence) 47.1 36.2 47.0
  Injury/poisoning (%) No = 0, yes = 1 (12-month prevalence) 10.8 10.4 10.8
  Joint pain (%) No = 0, yes = 1 (12-month prevalence) 77.6 53.5 77.5
  Kidney failure (%) No = 0, yes = 1 (lifetime prevalence) 2.2 1.5 2.2
  Migraine (%) No = 0, yes = 1 (lifetime prevalence) 23.3 10.1 23.3
  Prostatic hyperplasia (%) No = 0, yes = 1 (lifetime prevalence) 7.6 7.9 7.6
  Rheumatoid arthritis (%) No = 0, yes = 1 (lifetime prevalence) 4.5 2.3 4.5
  Thyroid disease (%) No = 0, yes = 1 (lifetime prevalence) 33.2 23.1 33.1
  Not specified other diseases (%) No = 0, yes = 1 (current impairment/treatment) 53.8 38.0 53.7

CASMIN Comparative Analysis of Social Mobility in Industrial Nations

aN = 4540 observations in the control group were downweighted in order to match the group of individuals with depression